Gravity Analytica

TransMedics to Host Investor & Analyst Day on December 10, 2024

TMDX 11.26.2024

SERA-AI Powered Highlights

Date of Upcoming Event:2024-12-10

Name of Upcoming Event:Investor & Analyst Day

Full Press Release SEC Filings Our TMDX Tweets

About Gravity Analytica

Recent Filings

ANDOVER, Mass.,Nov. 26, 2024/PRNewswire/ --TransMedics Group, Inc.("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that it will host an Investor & Analyst Day inNew York CityonTuesday, December 10, 2024, at10:00 AM ET.

Waleed Hassanein, MD., President and Chief Executive Officer, and members of the leadership team will present an overview ofTransMedics'growth strategy, clinical pipeline, and operations.

A live and archived webcast of presentations and Q&A sessions will be available on the "Investors" section of theTransMedicswebsite athttps://investors.transmedics.com. Please note management will only take questions from the live audience during the question-and-answer session following the formal presentations.

In-person attendance at the event requires advanced registration. Please emailLaine Morganatlaine@gilmartinir.combyDecember 4, 2024, for further information.

AboutTransMedics Group, Inc.TransMedicsis the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered inAndover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:Brian JohnstonLaine Morgan332-895-3222Investors@transmedics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-host-investor--analyst-day-on-december-10-2024-302316931.html

SOURCETransMedics Group, Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com